In randomized managed trials, there are two treatment solutions at the moment regarded as the typical of treatment in Guillain-Barré syndrome (GBS). These contain either intravenous immunoglobulin (IVIG) or plasma https://ksnr.org.in/guillain-barre-syndrome/